Evidence map›Paper›PMID 42322953›Full record

ArticleRedox biology2026

XRCC1 deficiency drives telomeric chromatin leakage, inflammatory signalling and senescence.

Anna Piscone, Francesca Gorini, Susanna Ambrosio, Carmen Caiazza, Giannicola Marotta, Anna Noviello, Giovanni Di Fusco, Giovanni Scala, Barbara Majello, Stefano Amente

Abstract read
In one paragraph

Article in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anna PisconeDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy.
Francesca GoriniDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy.
Susanna AmbrosioDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
Carmen CaiazzaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy.
Giannicola MarottaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy.
Anna NovielloDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
Giovanni Di FuscoDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
Giovanni ScalaDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
Barbara MajelloDepartment of Biology, University of Naples 'Federico II', Naples, Italy.
Stefano AmenteDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', Naples, Italy. Electronic address: stamente@unina.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome integrity is constantly challenged by oxidative DNA damage, which, if left unrepaired, can result in replication stress, chromosomal instability, and tumorigenesis. The base excision repair (BER) pathway is essential for resolving oxidative base lesions such as 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG). Among BER factors, APE1 and XRCC1 play critical roles not only in lesion repair but also in maintaining replication fork stability. Here, we investigate the cellular consequences of APE1 and XRCC1 deficiency in isogenic breast epithelial models (MCF10A and MCF7), under basal and oxidative stress conditions to better dissect the mechanisms through which these factors safeguard genome integrity. We show that XRCC1 deficiency, more than APE1 depletion, leads to an increase of the DNA damage signalling, and the formation of cytoplasmic chromatin fragments (CCFs) containing telomeric DNA. XRCC1-deficient cells also exhibit activation of the cGAS-STING pathway, inflammatory signalling, and senescence phenotypes. Our findings identify XRCC1 as a central suppressor of oxidative stress-induced cytosolic DNA accumulation and immune signalling. These results suggest that targeting XRCC1 may offer a therapeutic avenue to trigger tumour senescence and promote anti-tumour immunity.

Indexed as

Cellular SenescenceChromatinInflammationTelomereX-ray Repair Cross Complementing Protein 1cGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA RepairExcision RepairHumansNucleotidyltransferasesOxidative StressSignal TransductionAPEX1 protein, humanChromatinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseDNA-(Apurinic or Apyrimidinic Site) LyaseNucleotidyltransferasesX-ray Repair Cross Complementing Protein 1XRCC1 protein, human

Identifiers

PMID42322953
PMCPMC13310650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.